← Leaderboards
Ernesto Roque Bongarzone
University Of Illinois At Chicago
$5,828,807
Attributed
$5,828,807
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $606.6K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,828,807 · 3
By mechanism
R01$5,402,900 · 2
R21$425,907 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Dawood Darbar$15,920,976
- Gerardo Andres Morfini$3,934,984
- Gregory J Heller$209,456
- Ramona Pufan$87,685
- Tuba Fehr$176,682
Others in their field
Top investigators on “Myelin”
- James J Lah · Emory University$35,158,235
- Stephen Arthur Back · Oregon Health & Science University$23,494,618
- Vijay K Kuchroo · Brigham And Women'S Hospital$22,841,024
- Jeff W Lichtman · Washington University$21,489,807
- Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru$21,079,355
- Brian J Popko · Northwestern University$20,097,136
Research focus
MyelinNeurologicComplementNeuronsMediatingEnzymesPostnatalLeukodystrophyLifePsychosineAffectGloboid Cell LeukodystrophyCellsGalactosylceramidaseBrainBaseNovel TherapeuticsDesignAnimal ModelMissionMouse ModelDemyelinationsNerve DegenerationNeuroprotection
Grant awards (15)
CGT and ACD Inhibitors for SRT Treatment of Krabbe Disease$589,359
R01 · FY2025 · NS · contact PI
CGT and ACD Inhibitors for SRT Treatment of Krabbe Disease$571,923
R01 · FY2024 · NS · contact PI
CGT and ACD Inhibitors for SRT Treatment of Krabbe Disease$589,813
R01 · FY2023 · NS · contact PI
CGT and ACD Inhibitors for SRT Treatment of Krabbe Disease$606,620
R01 · FY2022 · NS · contact PI
Combined Neuroprotection and Metabolic Correction to Treat Leukodystrophies$349,781
R01 · FY2018 · NS · contact PI
Combined Neuroprotection and Metabolic Correction to Treat Leukodystrophies$349,781
R01 · FY2017 · NS · contact PI
Combined Neuroprotection and Metabolic Correction to Treat Leukodystrophies$349,781
R01 · FY2016 · NS · contact PI
Combined Neuroprotection and Metabolic Correction to Treat Leukodystrophies$349,581
R01 · FY2015 · NS · contact PI
Therapies to Stimulate Remyelination$217,988
R21 · FY2015 · NS · contact PI
Therapies to Stimulate Remyelination$207,919
R21 · FY2014 · NS · contact PI
Combined neuroprotection and metabolic correction to treat leukodystrophies$320,034
R01 · FY2013 · NS · contact PI
Combined neuroprotection and metabolic correction to treat leukodystrophies$331,642
R01 · FY2012 · NS · contact PI
Combined neuroprotection and metabolic correction to treat leukodystrophies$331,642
R01 · FY2011 · NS · contact PI
Combined neuroprotection and metabolic correction to treat leukodystrophies$335,027
R01 · FY2010 · NS · contact PI
Combined neuroprotection and metabolic correction to treat leukodystrophies$327,916
R01 · FY2009 · NS · contact PI